Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Share (Details)

v3.23.3
Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Share (Details)
 3 Months Ended 9 Months Ended
Nov. 02, 2023
D
$ / shares
Sep. 19, 2022
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
shares
Jul. 14, 2023
USD ($)
$ / shares
Dec. 31, 2022
$ / shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Common stock, par value (in dollars per share) | $ / shares     $ 0.0001   $ 0.0001     $ 0.0001
Proceeds from Issuance of Common Stock | $   $ 5,000,000     $ 1,156,443      
Subsequent Events.                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Consecutive business days | D 30              
Bid price per share | $ / shares $ 1.00              
Threshold business days 10 days              
Additional compliance period 180 days              
Capital on Demand Sales Agreement [Member]                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Common stock, par value (in dollars per share) | $ / shares             $ 0.0001  
Aggregate offering price | $             $ 6,700,000  
Proceeds from Issuance of Common Stock | $     $ 1,355,090          
Stock options                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Anti-dilutive securities | shares     1,943,647 1,304,147 1,943,647 1,304,147    
Warrants                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Anti-dilutive securities | shares     193,875 672,500 193,875 672,500